Your prediction
Novozymes A/S B Stock
We can see a decrease in the price for Novozymes A/S B. Compared to yesterday it has lost -€0.780 (-1.500%).
Our community identified positive and negative aspects for Novozymes A/S B stock for the coming years. 1 users see the criterium "Return on equity" as a plus for the Novozymes A/S B stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Novozymes A/S B in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novozymes A/S B vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novozymes A/S B | -1.500% | -0.192% | -4.171% | -2.662% | -5.186% | 13.091% | 1.565% |
| Solvay S.A. A | 0.430% | 1.012% | 7.291% | -10.699% | 2.343% | -73.808% | -73.282% |
| FMC Corp. | 1.600% | -3.482% | -14.483% | -67.530% | 0.727% | -90.358% | -86.342% |
| Covestro AG | -0.030% | -0.197% | 0.066% | 3.338% | 0.831% | 50.087% | -0.687% |
